Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 17 | 24 | +7 |
| Shares | 610.2K | 3.54M | +2.93M (+479.9%) |
| Value | $214.8K | $778.4K | +$563.6K (+262.4%) |
New holders (8)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,554,442 | $562.0K | 0.01% |
| Northern Trust Corp | 65,979 | $14.5K | 0.00% |
| Virtu Financial LLC | 63,827 | $14.0K | 0.00% |
| XTX Topco Ltd | 52,097 | $11.5K | 0.00% |
| StoneX Group Inc. | 19,451 | $4.28K | 0.00% |
| Susquehanna International Group, LLP | 12,087 | $2.66K | 0.00% |
| Harbour Investments, Inc. | 99 | $22 | 0.00% |
| Citigroup Inc | 1 | $0 | 0.00% |
Sold out (1)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| HRT Financial LP | 11,191 | $3.00K |